Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock transactions, according to a recent SEC filing. On February 3, Benkowitz sold shares ...
The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...
The research offers hope to tens of thousands of patients with kidney failure who are on a long waiting list for an organ ...
The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people ...
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...